For the Inventor, By the Inventor

Enter inventor name

San Francisco, CA, United States of America

Jan Zur Megede

USPTO Granted Patents = 18 (Patent Applications = 7)

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 108(Granted Patents)

Location History:

Larkspur, CA (US) (2012)
Emeryville, CA (US) (2012 - 2014)
San Francicso, CA (US) (2016)
San Francisco, CA (US) (2003 - 2017)

Company Filing History:

Novartis Vaccines & Diagnostics, Gmbh

Chiron Corporation

Universaity of Stellenbosch

5. 1 out of 832,912

Other

patents

where one patent can have more than one assignee

Years Active: 2003-2017

Loading Chart...

Loading Chart...

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9598469 - HIV-1 south african subtype C env proteins (2017-03-21),

2. 9234181 - RNA expression cassette and cells for making alphavirus particles (2016-01-12),

3. 8637044 - Method of generating an immune response in a subject using fusion proteins comprising CD4 minimal modules and HIV Tat scaffold polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopes (2014-01-28),

4. 8541230 - Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof (2013-09-24),

5. 8518694 - Nucleic acid vector comprising a promoter and a sequence encoding a polypeptide from the endogenous retrovirus PCAV (2013-08-27),

6. 8263394 - Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides, and uses thereof (2012-09-11),

7. 8173137 - Polycistronic HIV vector constructs (2012-05-08),

8. 8168418 - Expression of HIV polypeptides and production of virus-like particles (2012-05-01),

9. 8168194 - Fusion proteins comprising CD4 minimal modules and human immunodeficiency virus (HIV) Tat scaffold polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopes (2012-05-01),

10. 8133494 - Expression cassettes endcoding HIV-1 south african subtype C modified ENV proteins with deletions in V1 and V2 (2012-03-13),

11. 7943375 - Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof (2011-05-17),

12. 7935805 - Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof (2011-05-03),

13. 7718401 - Expression of HIV polypeptides and production of virus-like particles (2010-05-18),

14. 7622125 - Polycistronic HIV vector constructs (2009-11-24),

15. 7618642 - Expression cassettes encoding modified human immunodeficiency virus type 1 subtype C envelope glycoproteins (2009-11-17),

Title: The Innovative Journey of Jan Zur Megede

Introduction: Jan Zur Megede is a pioneering inventor based in San Francisco, CA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Jan Zur Megede holds several patents in various technological domains, including artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and creativity.

Career Highlights: Throughout his illustrious career, Jan Zur Megede has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have revolutionized industries and improved the lives of many.

Collaborations: Jan Zur Megede has collaborated with leading research institutions, universities, and tech companies to further his inventions and bring them to market, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Jan Zur Megede's relentless pursuit of innovation and his passion for creating impactful solutions have solidified his reputation as a visionary inventor in the vibrant tech hub of San Francisco, CA.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…